TrialPloS one2017

Topical Recombinant Human Epidermal Growth Factor for Oral Mucositis Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.

Ji-Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.